dexmedetomidine has been researched along with Depression in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 4 (80.00) | 2.80 |
Authors | Studies |
---|---|
He, M; Xu, S; Zhang, X; Zhao, X; Zheng, X; Zhu, Z | 1 |
Ishiguro, M; Kakizaki, R; Narimatsu, E; Nomura, K; Sawamoto, K; Takahashi, K; Uemura, S | 1 |
Al-Alawi, M; Brietzke, E; Carvalhal, A; Soares, CN | 1 |
Bueno, H; Cortés-Beringola, A; Domínguez-Pérez, L; Martín-Asenjo, R; Maruri, R; Moreno, G; Puerto, E; Vicent, L; Vidán, MT | 1 |
Fish, DN; Kiser, TH; Lavelle, JC; MacLaren, R; Malkoski, SP; Mueller, SW; Preslaski, CR | 1 |
2 review(s) available for dexmedetomidine and Depression
Article | Year |
---|---|
The potential anti-depressant properties of dexmedetomidine infusion: a review of mechanistic, preclinical, and clinical evidence.
Topics: Antidepressive Agents; Depression; Depressive Disorder, Major; Dexmedetomidine; Drug Resistance; Humans; Signal Transduction | 2020 |
Diagnosis, prevention, and management of delirium in the intensive cardiac care unit.
Topics: Antipsychotic Agents; Coronary Care Units; Delirium; Dementia; Depression; Dexmedetomidine; Diagnosis, Differential; Humans; Hypnotics and Sedatives; Psychotic Disorders; Risk Assessment | 2021 |
1 trial(s) available for dexmedetomidine and Depression
Article | Year |
---|---|
A randomized, double-blind pilot study of dexmedetomidine versus midazolam for intensive care unit sedation: patient recall of their experiences and short-term psychological outcomes.
Topics: Adult; Aged; Anxiety; Conscious Sedation; Critical Care; Depression; Dexmedetomidine; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Intensive Care Units; Male; Mental Recall; Midazolam; Middle Aged; Pilot Projects; Stress Disorders, Traumatic, Acute; Surveys and Questionnaires | 2015 |
2 other study(ies) available for dexmedetomidine and Depression
Article | Year |
---|---|
A New Potential Antidepressant: Dexmedetomidine Alleviates Neuropathic Pain-Induced Depression by Increasing Neurogenesis in the Hippocampus.
Topics: Animals; Antidepressive Agents; Bromodeoxyuridine; Chronic Pain; Corticosterone; Depression; Dexmedetomidine; Hippocampus; Mice; Neuralgia; Neurogenesis; Sucrose | 2022 |
Dexmedetomidine improves excessive extracellular glutamate-induced synaptic depression (BRAINRES-D-21-00941).
Topics: Animals; Depression; Dexmedetomidine; Dobutamine; Glutamic Acid; Hippocampus; Isoproterenol; Rats; Receptors, Adrenergic; Synaptic Transmission | 2022 |